June 9, 2020 / 6:34 AM / a month ago

BRIEF-Avacta Says BAMS Diagnostic Test For COVID-19 Reached Prototype Stage

June 9 (Reuters) - Avacta Group PLC:

* AVACTA GROUP PLC - UPDATE ON COVID-19 TEST DEVELOPMENT WITH ADEPTRIX

* AVACTA - BAMS(TM) DIAGNOSTIC TEST FOR COVID-19 REACHED PROTOTYPE STAGE AND CAN DETECT CORONAVIRUS SPIKE PROTEIN IN MODEL SAMPLES

* AVACTA GROUP PLC - PROTOTYPE ASSAY HAS NOW BEEN DEVELOPED AND EVALUATED BY ADEPTRIX USING MODEL SAMPLES CONTAINING CORONAVIRUS SPIKE PROTEIN

* AVACTA GROUP PLC - NOW LOOKING FORWARD TO TESTING PROTOTYPE BAMS ASSAY WITH PATIENT SAMPLES IN UK VERY SOON

* AVACTA GROUP PLC - CONTINUE TO MAKE VERY GOOD PROGRESS WITH CYTIVA ON SALIVA-BASED ANTIGEN TEST Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below